Jiangluyi Cai

1278 Baode Road
Jing'an, 200443, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Author Correction: Double-stranded RNA and ROS scavenging nanoplatform for modulating skin inflammation.

Author Correction: Double-stranded RNA and ROS scavenging nanoplatform for modulating skin inflammation.

Journal: Nature communications

Published: September 03, 2026

Comprehensive Metabolomic Profiling of Skin Lesions from Psoriasis Patients Reveals Disease Signatures.

Comprehensive Metabolomic Profiling of Skin Lesions from Psoriasis Patients Reveals Disease Signatures.

Journal: International journal of biological sciences

Published: March 08, 2026

Development and validation of a prediction model for primary non-response to IL-17A inhibitors in psoriasis.

Development and validation of a prediction model for primary non-response to IL-17A inhibitors in psoriasis.

Journal: Frontiers in medicine

Published: November 10, 2025

Comment on "Gas Bubbles From Biodegradable Magnesium Implants Convey Mechanical Cues and Promote Immune Cell Stimulation".

Comment on "Gas Bubbles From Biodegradable Magnesium Implants Convey Mechanical Cues and Promote Immune Cell Stimulation".

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: September 15, 2025

Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

Journal: Drugs

Published: July 17, 2025

Cryptochrome 2 stabilization alleviates psoriasis by inhibiting keratinocyte hyperproliferation and inflammation.

Cryptochrome 2 stabilization alleviates psoriasis by inhibiting keratinocyte hyperproliferation and inflammation.

Journal: International immunopharmacology

Published: July 03, 2025

IL-27 signaling mediates skin inflammation in experimental psoriasis and atopic dermatitis.

IL-27 signaling mediates skin inflammation in experimental psoriasis and atopic dermatitis.

Journal: Cell & bioscience

Published: June 30, 2025

Baseline Th17/Tc17 and LAG-3 levels serve as candidate exploratory markers for early ixekizumab response in psoriasis.

Baseline Th17/Tc17 and LAG-3 levels serve as candidate exploratory markers for early ixekizumab response in psoriasis.

Journal: Frontiers in immunology

Published: June 24, 2025

Association of β-blockers with methotrexate efficacy in psoriasis patients with hypertension: A retrospective cohort study.

Association of β-blockers with methotrexate efficacy in psoriasis patients with hypertension: A retrospective cohort study.

Journal: Journal of the American Academy of Dermatology

Published: March 26, 2025

Reprogramming of Fatty Acid Metabolism via PPARα-Orchestrated FADS2 in Keratinocytes Modulates Skin Inflammation in Psoriasis.

Reprogramming of Fatty Acid Metabolism via PPARα-Orchestrated FADS2 in Keratinocytes Modulates Skin Inflammation in Psoriasis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 17, 2024

N6-methyladenosine modification-tuned lipid metabolism controls skin immune homeostasis via regulating neutrophil chemotaxis.

N6-methyladenosine modification-tuned lipid metabolism controls skin immune homeostasis via regulating neutrophil chemotaxis.

Journal: Science advances

Published: October 02, 2024

Double-stranded RNA and ROS scavenging nanoplatform for modulating skin inflammation.

Double-stranded RNA and ROS scavenging nanoplatform for modulating skin inflammation.

Journal: Nature communications

Published: July 01, 2024

Showing 1-12 of 15

Last Updated: 09/26/2026